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Abstract. 
 
The interaction of cadherin–catenin complex 
with the actin-based cytoskeleton through 
 
a
 
-catenin is 
indispensable for cadherin-based cell adhesion activity. 
We reported previously that E-cadherin–
 
a
 
-catenin fu-
sion molecules showed cell adhesion and cytoskeleton 
binding activities when expressed in nonepithelial
L cells. Here, we constructed deletion mutants of
E-cadherin–
 
a
 
-catenin fusion molecules lacking various 
domains of 
 
a
 
-catenin and introduced them into L cells. 
Detailed analysis identiﬁed three distinct functional do-
mains of 
 
a
 
-catenin: a vinculin/
 
a
 
-actinin-binding do-
main, a ZO-1-binding domain, and an adhesion-modu-
lation domain. Furthermore, cell dissociation assay 
revealed that the fusion molecules containing the
ZO-1-binding domain in addition to the adhesion-mod-
ulation domain conferred the strong state of cell adhe-
sion activity on transfectants, although those lacking 
the ZO-1-binding domain conferred only the weak 
state. The disorganization of actin-based cytoskeleton 
by cytochalasin D treatment shifted the cadherin-based 
cell adhesion from the strong to the weak state. In the 
epithelial cells, where 
 
a
 
-catenin was not precisely colo-
calized with ZO-1, the ZO-1-binding domain did not 
completely support the strong state of cell adhesion
activity. Our studies showed that the interaction of
 
a
 
-catenin with the actin-based cytoskeleton through
the ZO-1-binding domain is required for the strong 
state of E-cadherin–based cell adhesion activity.
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 cadherins are a family of transmembrane pro-
teins responsible for Ca
 
2
 
1
 
-dependent cell–cell adhe-
sion (Takeichi, 1991). Intracellularly, they interact
with a group of proteins collectively termed catenins
(Ozawa et al., 1989; Nagafuchi et al., 1993). Association
with catenins is necessary for cadherins to express their
full function as cell adhesion molecules, and this complex
is now regarded as a functional unit for cell adhesion. A
unique property of this cadherin–catenin complex is its in-
timate interaction with the actin-based cytoskeleton. At
cell–cell contact sites, this complex is colocalized with ac-
tin filaments and resists nonionic detergent extraction
(Hirano et al., 1987). This complex is a major constituent
of intercellular adherens junctions (AJ),
 
1
 
 where actin fila-
ments are densely associated with the plasma membrane
through its well-developed plaque structure (Tsukita et al.,
1993). Although the cytoskeletal interaction of cadherin–
catenin complex is thought to be essential for adhesion,
the detailed molecular mechanism of this interaction re-
mains elusive.
 
a
 
-Catenin associates with the COOH-terminal end of
the cadherin cytoplasmic domain (catenin-binding site) via
 
b
 
-catenin. Sequence analysis showed that 
 
a
 
-catenin has
similarity to vinculin, another constituent of AJ (Herren-
knecht et al., 1991; Nagafuchi et al., 1991), which interacts
with various actin-based cytoskeletal components includ-
ing actin itself (Jockusch et al., 1995). This suggested that
 
a
 
-catenin may interact with the actin-based cytoskeleton.
 
a
 
-Actinin, ZO-1, vinculin, and actin itself were reported to
interact directly with 
 
a
 
-catenin (Rimm et al., 1995; Itoh et al.,
1997; Nieset et al., 1997; Watabe-Uchida et al., 1998; Weiss
et al., 1998). ZO-1 was identified originally as a tight
junction (TJ)-associated peripheral membrane protein
(Stevenson et al., 1986; Anderson et al., 1988), but it is also
concentrated at cadherin-based cell–cell contact sites to-
gether with vinculin in nonepithelial cells lacking TJ such
as fibroblasts and cardiac muscle cells (Itoh et al., 1993).
The functions of 
 
a
 
-catenin have been analyzed mainly
using two cell lines, the human lung carcinoma cell line
PC9, and L cells, a mouse fibroblast cell line. PC9 cells ex-
press E-cadherin and 
 
b
 
-catenin but not 
 
a
 
-catenin. They do
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not form tight cell aggregates after rotation culture and re-
sultant aggregates are easily dissociated into single cells
(Shimoyama et al., 1992). The exogenous expression of
 
a
 
-catenin in these cells restored not only the full cell adhe-
sion activity of cadherins but also the cadherin–cytoskele-
ton interaction (Hirano et al., 1992; Watabe et al., 1994).
Mouse L fibroblasts do not express cadherin molecules
and lack the cadherin-based cell adhesion activity. When
E-cadherin was introduced into L cells, stable transfec-
tants showed the full cell adhesion activity through the in-
teraction of introduced E-cadherin with endogenous 
 
a
 
-
and 
 
b
 
-catenins, but the mutant E-cadherin lacking the
catenin-binding site did not confer such cell adhesion ac-
tivity on L cells (Nagafuchi et al., 1987; Nagafuchi and
Takeichi, 1988; Ozawa et al., 1989). When the full-length
or COOH-terminal half of 
 
a
 
-catenin was covalently con-
nected to this nonfunctional mutant E-cadherin, these fu-
sion molecules showed the full cell adhesion activity in L
cells without interacting with endogenous catenins. More-
over, the introduced fusion molecules were associated
with the cytoskeleton (Nagafuchi et al., 1994). These find-
ings indicated that 
 
a
 
-catenin, especially its COOH-termi-
nal half, is crucial for the full cadherin-based cell adhesion
activity as well as cadherin–cytoskeleton interaction.
The L cell transfection system is advantageous for ex-
amination of the function of the cadherin–catenin complex
in cell adhesion and cytoskeleton interaction. Since L cells
show little cell–cell adhesion activity, these functions of in-
troduced cadherin or its fusion molecules can be selec-
tively analyzed. Using this system, we examined the do-
mains of 
 
a
 
-catenin responsible for the cadherin-based cell
adhesion activity and the interaction with cytoskeletal
components such as ZO-1, vinculin, and 
 
a
 
-actinin. We also
evaluated the functions of these 
 
a
 
-catenin functional do-
mains in 
 
a
 
-catenin–deficient epithelial cell lines.
 
Materials and Methods
 
Cells and Antibodies
 
Mouse L cells were grown in DME supplemented with 10% FCS. Trans-
fectants expressing E-cadherin (EL
 
b
 
1; Nose et al., 1988), nE
 
a
 
(1-906),
nE
 
a
 
N(1-508), and nE
 
a
 
C(509-906) (nE
 
a
 
L2, nE
 
a
 
NL28, and nE
 
a
 
CL1, re-
spectively; Nagafuchi et al., 1994), and other E-cadherin–
 
a
 
-catenin fusion
molecules (see Fig. 1) were grown in the same medium containing 150 
 
m
 
g/
ml of G418. nE
 
a
 
(1-906), nE
 
a
 
N(1-508), and nE
 
a
 
C(509-906) were origi-
nally called nE
 
a
 
, nE
 
a
 
N, and nE
 
a
 
C, respectively (Nagafuchi et al., 1994).
We named transfectants by combining the name of the fusion protein with
L; for example, L cells expressing nE
 
a
 
(1-906) were designated as nE
 
a
 
(1-
906)L cells. Mouse PC9 cells were grown in a 1:1 mixture of DME and
Ham’s F12 supplemented with 10% FCS (DH10). PC9 cells expressing
 
a
 
(1-184/509-643)-HA (see below) were grown in the same medium con-
taining 150 
 
m
 
g/ml of G418. Human colon carcinoma DLD-1/R2/7, abbre-
viated to R2/7, and its transfectants expressing 
 
a
 
E(1-890), 
 
a
 
E(1-325/510-
890), 
 
a
 
E(1-509), and 
 
a
 
E(1-325) (Watabe-Uchida et al., 1998) were also
cultured in DH10 medium.
Mouse anti–ZO-1 mAb (T8-754) was obtained and characterized as de-
scribed (Itoh et al., 1991). Anti–E-cadherin mAb (ECCD-2), which was
concentrated by ammonium sulfate precipitation, was a generous gift from
Dr. M. Takeichi (Kyoto University, Kyoto, Japan; Shirayoshi et al., 1986).
Mouse anti-vinculin mAb (hVIN-1) and mouse anti–
 
a
 
-actinin mAb
(BM-75.2) were purchased from Sigma Chemical Co. Mouse anti–HA-tag
mAb (12CA5) was purchased from Boehringer Mannheim Biochemicals.
Cy2-labeled anti–rat IgG and Cy3-labeled anti–mouse IgG antibodies
were purchased from Amersham. DTAF (dichlorotriazinyl amino fluo-
rescence)-labeled anti–rat IgG was purchased from Chemicon Interna-
tional, Inc.
 
Constructs
 
We constructed pBATE
 
a
 
(327-906), pBATE
 
a
 
(631-906), pBATE
 
a
 
(1-643),
pBATE
 
a
 
(509-643), pBATE
 
a
 
(1-325/509-906), and pBATE
 
a
 
(1-402/509-
906), expression vectors for nE
 
a
 
(327-906), nE
 
a
 
(631-906), nE
 
a
 
(1-643),
nE
 
a
 
(509-643), nE
 
a
 
(1-325/509-906), and nE
 
a
 
(1-402/509-906), respectively
(see Fig. 1). For construction of these vectors, we used three plasmids: (a)
pBATEM2, mouse E-cadherin expression vector (Nose et al., 1988), the
ClaI-XbaI fragment of which corresponds to the catenin-binding site and
was replaced with the 
 
a
 
-catenin cDNA fragments in constructs; (b)
pSK102B, which contains the 
 
a
 
-catenin cDNA with a PstI-BglII adaptor
inserted into the PstI site just before the initiation methionine codon; and
(c) pBATE
 
a
 
, the ClaI-XbaI fragment of pBATEM2 was replaced with
the BglII-XbaI fragment of pSK102B including the whole ORF of the
 
a
 
-catenin cDNA (Nagafuchi et al., 1994). In the open reading frame of the
 
a
 
-catenin cDNA sequence, we used four restriction sites, PmaCI, ScaI,
ClaI, and SmaI, corresponding to amino acid residues 326, 403, 508, and
670, respectively. The XbaI site at the 3
 
9
 
 terminal of 
 
a
 
-catenin cDNA in
pSK102B was also used. For the production of pBATE
 
a
 
(327-906), the
ClaI-XbaI fragment of pBATEM2 was replaced with the PmaCI-XbaI
fragment of pSK102B. For construction of pBATE
 
a
 
(631-906), a ClaI site
(630ClaI) was introduced at the position corresponding to amino acid res-
idue 630 of 
 
a
 
-catenin cDNA in pSK102B by PCR, then the ClaI-XbaI
fragment of pBATEM2 was replaced with the 630ClaI-XbaI fragment.
For production of pBATE
 
a
 
(1-643), an XbaI site (644XbaI) was intro-
duced at a position corresponding to amino acid residue 644 of 
 
a
 
-catenin
cDNA in pSK102B by PCR, then the ClaI-XbaI fragment of pBATE
 
a
 
was replaced with the ClaI-644XbaI fragment. For production of
pBATE
 
a
 
(1-325/509-906) and pBATE
 
a
 
(1-402/509-906), the PmaCI-ClaI
and the ScaI-ClaI fragments, respectively, were excised from pBATE
 
a
 
.
All junctions newly produced in the 
 
a
 
-catenin coding sequence were ar-
ranged in frame using adaptors or linkers as necessary.
For construction of pEF
 
a
 
(1-184/509-643)-HA, an EcoRI site (185
EcoRI) was introduced at the position corresponding to amino acid resi-
due 185 of 
 
a
 
-catenin cDNA in pSK102B by PCR. The BglII-185EcoRI
fragment, ClaI-644XbaI fragment, and a HA
 
a
 
3
 
9
 
 fragment, which contains
an HA epitope tag sequence, a stop codon, and 3
 
9
 
 noncoding region of
 
a
 
-catenin, were tandemly ligated and inserted into the pEFMC1-neo ex-
pression vector (Visvader et al., 1992).
We also constructed pGEX-
 
a
 
N(1-508), pGEX-
 
a
 
C(509-906), and
pGEX-
 
a
 
(671-906), expression vectors for GST–
 
a
 
-catenin fusion mole-
cules, using pSK102B and pGEX vectors (Pharmacia LKB Biotechnol-
ogy). For production of pGEX-
 
a
 
N(1-508), pGEX-
 
a
 
C(509-906), and
pGEX-
 
a
 
(631-906), the BglII-ClaI, ClaI-XbaI, and SmaI-EcoRI fragments
of pSK102B were inserted into the BamHI-SmaI sites of pGEX-2T, the
SmaI site of pGEX-3X, and the SmaI-XhoI sites of pGEX-4T-3 (Pharma-
cia LKB Biotechnology), respectively.
 
Transfection
 
L cells (5 
 
3
 
 10
 
5
 
 per 3-cm plate) were cotransfected with 1 
 
m
 
g of each ex-
pression vector and 0.05 
 
m
 
g of pSTneoB (Katoh et al., 1987) by the lipo-
fectamine method (Life Technologies, Inc.). After 48 h of incubation, the
cells were replated on pairs of 9-cm dishes and cultured in the presence of
400 
 
m
 
g/ml G418 to select stable transfectants. Colonies of G418-resistant
cells were isolated, recloned, and subsequently maintained in complete
medium with 150 
 
m
 
g/ml of G418. We isolated several stable clones for
each transfection experiment. Since nE
 
a
 
(327-906)L-11, nE
 
a
 
(631-906)L-7,
nE
 
a
 
(1-643)L-9, nE
 
a
 
(509-643)L-32, nE
 
a
 
(1-325/509-906)L-2, and nE
 
a
 
(1-
402/509-906)L-23 clones expressed relatively large amounts of fusion mol-
ecules, we mainly used these in this study.
Trypsinized PC9 cells (10
 
5
 
) were suspended in 500 
 
m
 
l of Hepes-buff-
ered (pH 7.4) Ca
 
2
 
1
 
- and Mg
 
2
 
1
 
-free saline and mixed with 10 
 
m
 
g of expres-
sion vector and 1 
 
m
 
g of pSTneoB. Electroporation was performed at 960
 
m
 
F, 250 V. The cells were selected in G418 (0.2 mg/ml)-containing me-
dium.
 
Immunohistochemistry
 
All procedures were performed at room temperature. Cells cultured on
coverslips were fixed with 3.5% (for hVIN-1 and BM-75.2) or 1.0% (for
T8-754) formaldehyde solution in HMF (Hepes-buffered magnesium-free
saline) for 15 min. After three washes with PBS, cells were soaked in
blocking solution (1% BSA in PBS) for 30 min and subsequently incu-
bated with ECCD-2 diluted with PBS containing 1% BSA for 30–60 min
at room temperature. The cells were then washed three times with PBS 
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and soaked in 0.2% Triton X-100 in PBS for 15 min. After rinsing with
PBS, the cells were treated with 1% BSA in PBS for 30 min and subse-
quently incubated with hVIN-1, T8-754, or BM-75.2 for 30–60 min. After
extensive washing with PBS, the specimens were incubated with fluores-
cence-labeled second antibodies (Cy2- or DTAF-labeled goat anti–rat
IgG for ECCD-2 and Cy3-labeled donkey anti–mouse IgG [H&L] for
hVIN-1, T8-754, and BM-75.2) diluted with PBS containing 1% BSA for
30 min at room temperature. After washing thoroughly with PBS, the
preparation was mounted with 90% glycerol-PBS containing 0.1% para-
phenylendiamine and 1% 
 
n
 
-propylgalate. Samples were observed with a
Zeiss Axiophot photomicroscope (Carl Zeiss). Images were recorded with
a cooled CCD camera (SenSys 0400, 768 
 
3
 
 512 pixels; Photometrics) con-
trolled by a Power Macintosh 7600/132 and the software package IPLab
Spectrum V3.1 (Signal Analytic Corp.).
 
SDS-PAGE and Immunoblotting
 
SDS-PAGE (10 or 7.5%) and immunoblotting were performed as de-
scribed previously (Nagafuchi et al., 1994). Samples were solubilized in
SDS sample buffer, separated by SDS-PAGE, and gels were stained with
Coomassie brilliant blue R-250. For immunoblotting, proteins were elec-
trophoretically transferred onto nitrocellulose sheets. Nitrocellulose mem-
branes were then incubated with ECCD-2, T8-754, or 12CA5. Antibody
detection was performed using an Amersham biotin-streptavidin kit with
biotinylated anti–rat or anti–mouse Ig and NBT-BCIP.
 
In Vitro Binding Assay Using GST Fusion Proteins
 
In vitro binding assays were performed as previously described (Itoh et al.,
1997). In brief, GST–
 
a
 
-catenin fusion proteins were expressed in 
 
Escheri-
chia coli
 
 and purified using glutathione-Sepharose 4B beads (Pharmacia
LKB Biotechnology) as previously described (Itoh et al., 1997). Then, 2 ml
of the cell lysate of Sf9 cells expressing N-ZO-1 was added, followed by in-
cubation for 3 h at 4
 
8
 
C. The beads were again washed with PBS containing
0.1% Triton X-100, 2 mM PMSF, and 4 
 
m
 
g/ml of leupeptin, and then
bound proteins were eluted with 1 ml of 50 mM Tris-HCl buffer, pH 8.0,
containing 10 mM glutathione. The amounts of GST fusion proteins in
each eluate were determined by SDS-PAGE.
 
Detergent Extraction of Cells
 
Confluent cultured cells (
 
z
 
4 3 106 cells per 6-cm dish) were extracted
with 2.5% NP-40 in HMF, then centrifuged at 100,000 rpm for 30 min as
described previously (Nagafuchi and Takeichi, 1988). To the supernatant,
23 SDS sample buffer was added to make the total volume 0.4 ml and
used as the detergent-soluble fraction. On the other hand, the pellet frac-
tion was dissolved in 0.4 ml of 13 SDS sample buffer and used as the de-
tergent-insoluble fraction.
Trypsin Treatment, Aggregation, and Dissociation
of Cells
Cells were trypsinized by two different methods for the differential re-
moval of E-cadherin or its fusion molecules, as described by Takeichi
(1977). In brief, cells were treated with 0.01% trypsin in the presence of
1 mM CaCl2 (TC treatment) or 1 mM EGTA (TE treatment) at 378C for
30 min. Generally, cadherins are left intact after TC treatment, but are di-
gested by TE treatment.
For the cell aggregation assay, cells were dispersed after TC treatment
as described by Takeichi (1977). L and R2/7 transfectants were pretreated
with 1 mM cytochalasin D in culture medium for 2 h. Although this treat-
ment is necessary for the dissociation of L cells expressing nEaC(509-906)
and R2/7 cells expressing aE(1-890), it did not affect cell aggregation of
other transfectants. Aliquots of 5 3 105 dissociated cells were plated in
each well of a Falcon 12-well plate with 0.5 ml HMF and allowed to aggre-
gate, as described previously (Nagafuchi et al., 1987). The extent of cell
aggregation was represented by the index Nt/N0 where Nt is the total parti-
cle number after incubation time t and N0 is the total particle number at
the initiation of incubation.
For the cell dissociation assay, confluent cultures were treated with TC
and TE and dissociated by pipetting 10 times (Nagafuchi et al., 1994). The
extent of cell dissociation was represented by NTC/NTE, where NTC and
NTE are the total particle number after TC and TE treatment, respec-
tively. In some experiments, confluent cultures were pretreated with 1 mM
cytochalasin D in culture medium for 2 h, then cell dissociation analyses
were performed in the presence of 1 mM cytochalasin D.
Results
Involvement of a-Catenin in the Recruitment of 
Vinculin and ZO-1 to Cadherin-based Cell–Cell 
Adhesion Sites
In L cell transfectants expressing E-cadherin, two cyto-
skeletal proteins, vinculin and ZO-1, are precisely colocal-
ized with E-cadherin at cell–cell contact sites (Itoh et al.,
1993). In parental L cells, vinculin is concentrated exclu-
sively at cell-substrate AJ, and ZO-1 does not show spe-
cialized localization but some condensation at tips of cellu-
lar processes (data not shown).
To determine whether a-catenin is involved in the re-
cruitment of vinculin and ZO-1 to E-cadherin–based cell
adhesion sites, we used L cell transfectants expressing
nEa(1-906), which is a fusion molecule consisting of non-
functional E-cadherin lacking its catenin-binding domain
and full-length a-catenin (Fig. 1 B; Nagafuchi et al., 1994).
As previously reported, this molecule showed similar cell
adhesion and cytoskeleton interaction activities to the nor-
mal E-cadherin–catenin complex. Immunocytochemical
analysis clearly revealed that both vinculin and ZO-1 were
precisely colocalized with nEa(1-906) at cell–cell contact
sites in L cell transfectants (Fig. 2). As reported previ-
ously, nonfunctional E-cadherin does not interact with the
cytoskeleton and nEa(1-906) is not associated with endog-
enous b-catenin (Nagafuchi and Takeichi, 1988; Ozawa et al.,
1989; Nagafuchi et al., 1994). These observations indicated
that a-catenin was crucial for the recruitment of vinculin
and ZO-1 to cell–cell contact sites in transfected L cells.
Involvement of Residues 327-402 of a-Catenin in the 
Recruitment of Vinculin
To determine the domain of a-catenin necessary for the
recruitment of vinculin or ZO-1, we constructed several
expression vectors encoding various E-cadherin–a-catenin
fusion molecules, in which distinct domains of a-catenin
were deleted (Fig. 1 B). These expression vectors were in-
troduced into mouse L cells, and stable transfectant clones
were isolated for each construct. Each mutant molecule
expressed in transfectants had the expected apparent mo-
lecular mass (Fig. 1 C).
The subcellular localization of vinculin was compared
with those of expressed fusion molecules in various trans-
fectants (Fig. 3). nEa(327-906) in which the NH2-terminal
326 residues had been truncated was precisely colocalized
with vinculin (Fig. 3, a and a9). However, nEaC(509-906)
with a longer NH2-terminal deletion showed no colocaliza-
tion with vinculin (Fig. 3, b and b9). In cells expressing
nEaN(1-508) with truncation of the COOH-terminal 398
residues, expressed fusion molecule was also colocalized
with vinculin at sites where it was heavily condensed (data
not shown). These observations suggested that residues
327-508 are important for the recruitment of vinculin.
Consistently, vinculin was not colocalized with nEa(1-325/
509-906) lacking residues 326-508 (Fig. 3, c and c9). Resi-
dues 326-508 of a-catenin include the direct a-actinin-
binding site (325-394 residues) reported previously (Nieset
et al., 1997). When this a-actinin-binding site was added to
nEa(1-325/509-906), the resultant fusion molecule nEa(1-
402/509-906) retained the ability to colocalize with vinculinThe Journal of Cell Biology, Volume 144, 1999 1314
(Fig. 3, d and d9). Double-immunostaining for E-cadherin
and a-actinin revealed that the constructs which recruited
vinculin, such as nEa(327-906) and nEa(1-402/509-906),
could recruit a-actinin (Fig. 4, a, a9, c, and c9). In contrast,
nEa(1-325/509-906) was not colocalized with either vincu-
lin or a-actinin (Fig. 4, b and b9). These results demon-
strated that residues 327-402 of a-catenin are crucial for
the recruitment of vinculin as well as a-actinin to cad-
herin-based cell adhesion sites of L cell transfectants (see
Fig. 11 A).
Involvement of the COOH-terminal Domain of
a-Catenin (Residues 631-906) in the Recruitment
of ZO-1
To determine the domain(s) of a-catenin involved in the
recruitment of ZO-1, we compared the subcellular local-
ization of ZO-1 with that of expressed fusion molecules in
transfectants. In contrast with vinculin, ZO-1 was not pre-
cisely colocalized with nEaN(1-508) but with nEaC(509-
906) (Fig. 5, a, a9, b, and b9). nEa(631-906), which had the
longest NH2-terminal deletion and showed no cell adhe-
sion activity (see below), was also colocalized with ZO-1 at
cell–cell boundaries (Fig. 5, c and c9), although their con-
densation at cell–cell boundaries was not as exclusive com-
pared with those in other transfectants. These observa-
tions strongly suggested that the COOH-terminal domain
of a-catenin (631-906 residues) is crucial for the recruit-
ment of ZO-1 (see Fig. 11 A).
We have reported previously that the NH2-terminal half
of ZO-1 (N-ZO-1) directly interacts with a-catenin (Itoh
et al., 1997). Therefore, it was expected that N-ZO-1
Figure 1. Schematic representation of E-cadherin–a-catenin fusion proteins. (A) E-cadherin–catenin complex and nonfunctional
E-cadherin. Direct binding of b-catenin (hatched boxes) to E-cadherin (dotted and closed boxes) and a-catenin (open boxes) links the
NH2-terminal domain of a-catenin to the COOH-terminal domain of E-cadherin. The COOH-terminal 70 amino acids of E-cadherin
(closed box) are responsible for catenin binding. E-cadherin lacking this catenin-binding domain did not interact with catenins and was
nonfunctional. (B) Fusion molecules between the nonfunctional E-cadherin and mutant a-catenins with various deletions (1–9). The
amino acid residues of a-catenin contained in fusion molecules are shown in parentheses. nEa(1-906), nEaN(1-508), and nEaC(509-
906) correspond to the previously reported fusion molecules nEa, nEaN, and nEaC, respectively (Nagafuchi et al., 1994). (C) Expres-
sion of fusion proteins in stable transfectants. Total lysates derived from 105 cells expressing nEa(1-906) (lane 1), nEa(327-906) (lane 2),
nEaC(509-906) (lane 3), nEa(631-906) (lane 4), nEaN(1-508) (lane 5), nEa(1-643) (lane 6), nEa(509-643) (lane 7), nEa(1-325/509-906)
(lane 8), and nEa(1-402/509-906) (lane 9) were separated by SDS-PAGE (7.5%) and immunoblotted with anti–E-cadherin mAb,
ECCD-2. The numbers marking the lanes in C correspond to the numbers of constructs in B. Several minor bands with lower molecular
mass, which may have been degradation products of fusion molecules, were detected. Size markers of 200, 116, 97, and 66 kD are indi-
cated on the left.
Figure 2. Subcellular localization of vinculin, ZO-1, and nEa(1-
906) in transfectants expressing nEa(1-906). Cells were doubly
stained with anti-vinculin mAb (a)/anti–E-cadherin (a9) or anti–
ZO-1 (b)/anti–E-cadherin (b9) mixture. nEa(1-906) was colocal-
ized with both vinculin and ZO-1. Bar, 25 mm.Imamura et al. Functional Domains of a-Catenin 1315
would directly interact with the COOH-terminal domain
of a-catenin. To test this possibility, we produced four
GST fusion proteins, GST-a(1-906), GST-aN(1-508), GST-
aC(509-906), and GST-a(671-906), which contained the
full-length  a-catenin, its NH2-terminal half, its COOH-ter-
minal half, or the COOH-terminal 236 residues, respec-
tively (Fig. 6 A). Then, we analyzed in vitro binding abili-
ties of these fusion molecules with recombinant N-ZO-1
produced in Sf9 cells by baculovirus infection. As shown
in Fig. 6 B, N-ZO-1 bound to not only GST-a(1-906) but
also GST-aC(509-906) and GST-a(671-906), although the
binding affinities to the latter two were lower than that
to the former. N-ZO-1 did not bind to GST-aN(1-508).
These results strongly suggested that the COOH-terminal
276 amino acids (residues 631-906) of a-catenin recruited
ZO-1 to cadherin-based cell–cell contact sites through its
direct binding to ZO-1 in transfected L cells.
Involvement of Residues 509-643 of a-Catenin in Cell 
Adhesion Activity of Fusion Molecules
We have reported previously that nEaC(509-906) shows
similar cell adhesion activity to the normal E-cadherin–
catenin complex (Nagafuchi et al., 1994). To determine the
domain which is required for this function, we compared
the reaggregative properties of L cell transfectants ex-
Figure 3. Subcellular localization of vinculin and E-cadherin–
a-catenin fusion proteins in transfectants expressing nEa(327-
906) (a and a9), nEaC(509-906) (b and b9), nEa(1-325/509-906) (c
and c9), and nEa(1-402/509-906) (d and d9). Cells were doubly
stained with anti-vinculin mAb (a–d) and anti–E-cadherin mAb
(a9–d9) mixture. Arrows indicate the colocalization of fusion mol-
ecules with vinculin. Arrowheads indicate the absence of vinculin
at cell–cell boundaries where fusion molecules were condensed.
Bar, 25 mm.
Figure 4. Subcellular localization of a-actinin and E-cadherin–
a-catenin fusion proteins in transfectants expressing nEa(327-
906) (a and a9), nEa(1-325/509-906) (b and b9), and nEa(1-402/
509-906) (c and c9). Cells were doubly stained with anti–a-actinin
mAb (a–c) and anti–E-cadherin mAb (a9–c9). Arrows indicate
the colocalization of fusion molecules with a-actinin. Arrow-
heads indicate the absence of a-actinin at cell–cell boundaries
where fusion molecules were condensed. Bar, 25 mm.
Figure 5. Subcellular localization of ZO-1 and E-cadherin–
a-catenin fusion proteins in transfectants expressing nEaN(1-
508) (a and a9), nEaC(509-906) (b and b9), and nEa(631-906) (c
and c9). Cells were doubly stained with anti–ZO-1 mAb (a–c) and
anti–E-cadherin mAbs (a9–c9). Arrows indicate the colocaliza-
tion of fusion molecules with ZO-1. Arrowheads indicate the ab-
sence of ZO-1 at cell–cell boundaries where fusion molecules
were condensed. Bar, 25 mm.The Journal of Cell Biology, Volume 144, 1999 1316
pressing nEa(509-643) and nEa(631-906); the former was
an nEaC(509-906) derivative lacking the ZO-1-binding
domain, and the latter contained only the ZO-1-binding
domain (see Fig. 1 B). Cells expressing nEa(509-643) ag-
gregated as rapidly as those expressing nEaC(509-906). In
contrast, the reaggregation of cells expressing nEa(631-
906) was indistinguishable from that of parent L cells (Fig.
7 A). These observations suggested that residues 509-643
of a-catenin are required for cell adhesion activity of fu-
sion molecules. Indeed, when residues 509-643 were added
to nEaN(1-508), cells expressing the resultant fusion mol-
ecule nEa(1-643) aggregated rapidly, although nEaN(1-
508) did not (Fig. 7 A). The levels of expression of
nEa(631-906) or nEaN(1-508) in the transfectants exam-
ined were relatively low among the fusion molecules ex-
amined (Fig. 1 C, lanes 4 and 5). However, the reduced
level of fusion molecule expression did not seem to be the
cause of loss of their cell adhesion activity since L cells ex-
pressing similar or lesser amounts of nEa(1-643) still ag-
gregated rapidly (data not shown). These results demon-
strated that residues 509-643 of a-catenin are required for
cell adhesion activity of E-cadherin–a-catenin fusion mol-
ecules in transfected L cells (see Fig. 11 A). We tentatively
called this an adhesion-modulation domain (see Fig. 11 B).
The cell adhesion activities of E-cadherin and its a-cate-
nin fusion molecules were reported to be associated with
their interactions with the cytoskeleton (Nagafuchi et al.,
1994; Sako et al., 1998). For example, about half of the
nEaC(509-906) was resistant to extraction with NP-40
(Fig. 8) Interestingly, most of the nEa(509-643) carrying
only the adhesion-modulation domain was extracted with
NP-40, suggesting that this fusion molecule did not inter-
act with the cytoskeleton (Fig. 8). In contrast, nEaN(1-
508) (data not shown; see Nagafuchi et al., 1994) and
nEa(631-906) (Fig. 8) did not show cell adhesion activity
but interacted with the cytoskeleton as judged from their
resistance to NP-40 extraction. In the cell aggregation as-
say, the disorganization of actin-based cytoskeleton by cy-
Figure 6. Association of a-catenin with N-ZO-1 in vitro. (A)
Schematic representation of fusion molecules between GST and
various domains of a-catenin. The amino acid residues of a-cate-
nin remaining in fusion molecules are shown in parentheses. (B)
Detection of proteins bound to GST-a(1-906), GST-aN(1-508),
GST-aC(509-906), and GST-a(671-906). GST fusion proteins
were bound to glutathione-Sepharose beads, and incubated with
the lysate of Sf9 cells expressing N-ZO-1. After washing, GST fu-
sion proteins were eluted together with their binding proteins
from the beads with a buffer containing glutathione. Proteins in
the eluates were separated by SDS-PAGE followed by Coo-
massie brilliant blue staining to estimate the amounts of GST fu-
sion protein in each eluate (GST fusion), or followed by immuno-
blotting with anti–ZO-1 mAb, T8-754, to detect N-ZO-1 bound
to GST fusion proteins (Bound N-ZO-1).
Figure 7. Aggregation and dissociation assay of L cell transfec-
tants. (A) Aggregation of L cells (open circles) and their trans-
fectants expressing nEaC(509-906) (closed circles), nEa(509-
643) (open squares), nEa(631-906) (closed squares), nEa(1-643)
(open triangles), and nEaN(1-508) (closed triangles). Cells disso-
ciated by TC treatment in the presence of cytochalasin D were al-
lowed to aggregate in the presence of 1 mM Ca21. The lower
value on the ordinate represents the higher degree of aggrega-
tion. (B and C) Dissociation of L cell transfectants expressing
nEaC(509-906) (black bar), nEa(509-643) (hatched bar), and
nEa(1-643) (white bar) in the absence (B) or in the presence (C)
of cytochalasin D. The lower value on the ordinate represents the
lower degree of dissociation.Imamura et al. Functional Domains of a-Catenin 1317
tochalasin D treatment essentially did not affect the cell
aggregating activity of any of the transfectants (data not
shown). These results suggested that cadherin-based
cell adhesion activity and cadherin–cytoskeleton inter-
action are regulated independently by distinct domains
of a-catenin.
Requirement of ZO-1-Binding Domain for the Strong 
State of Cell Adhesion
We demonstrated previously that cells assumed two states
of cadherin-based cell adhesion, strong and weak (Takeda
et al., 1995). The cell–cell adhesion in the strong state
could hardly be dissociated by pipetting, although that in
the weak state was easily dissociated. Using the cell disso-
ciation assay, we examined the states of cell adhesion of
various L cell transfectants. As reported previously, L cell
transfectants expressing nEaC(509-906), which contained
both the adhesion-modulation and ZO-1-binding domains
of a-catenin, were hardly dissociated in the cell dissocia-
tion assay, indicating that these cells showed the strong
state of cell adhesion activity (Fig. 7 B; Nagafuchi et al.,
1994). Intact E-cadherin or other fusion molecules con-
taining both of these domains also showed the strong state
of cell adhesion activity (data not shown; see Fig. 11 A). In
contrast, cells expressing nEa(509-643), which contained
only the adhesion-modulation domain of a-catenin, were
easily dissociated into single cells under the conditions of
the cell dissociation assay (Fig. 7 B), indicating that these
cells showed the weak state of cell adhesion activity. Inter-
estingly, cells expressing nEa(1-643) lacking only the ZO-
1-binding domain also showed the weak state of cell adhe-
sion activity (Fig. 7 B). It should be noted that nEa(1-643)
was hardly extracted with NP-40 (Fig. 8), suggesting its
interaction with the cytoskeleton probably through the
vinculin/a-actinin-binding domain. In the presence of cy-
tochalasin D, nEaC(509-906)L cells were also easily disso-
ciated under the same condition (Fig. 7 C), although the
amount of expressed nEaC(509-906) was not altered in
the presence or absence of cytochalasin D (data not
shown). These results indicated that the ZO-1-binding do-
main, but not the vinculin/a-actinin-binding domain, in ad-
dition to the adhesion-modulation domain was required
for the strong state of cell adhesion activity. It was also
suggested that the intact actin-based cytoskeleton is re-
quired for this type of adhesion activity.
Functions of a-Catenin in Epithelial Cells
We examined the role of a-catenin in epithelial cell adhe-
sion using a-catenin–deficient epithelial cell lines and their
transfectants expressing a-catenin deletion mutants. Since
cadherin–catenin complex is not colocalized with ZO-1 in
epithelial cells, the roles of a-catenin in epithelial cells are
expected to be different, at least in some aspects, from
those in nonepithelial cells such as L cells. DLD-1/R2/7,
abbreviated to R2/7, is an a-catenin–deficient colon carci-
noma line. R2/7 transfectants expressing a-catenin dele-
tion mutants were previously reported (Watabe-Uchida
et al., 1998). We used four of these transfectants in this
study.  a-Catenin deletion mutants expressed in these
transfectants are shown in Fig. 9 A. Using the cell aggrega-
tion assay, we compared the reaggregative properties of
R2/7 and its transfectants (Fig. 9 B). R2/7 itself showed
aggregation activity which was blocked in the presence
of E-cadherin blocking antibodies (data not shown, see
Watabe-Uchida et al., 1998). R2/7 transfectants expressing
aE(1-890), which is indistinguishable from cells expressing
intact  a-catenin, aggregated more rapidly than parental
R2/7 cells. Not only cells expressing aE(1-325/510-890) but
also those expressing aE(1-509), which lacks the adhesion-
modulation domain, also aggregated more rapidly than pa-
rental R2/7 cells. R2/7 cells expressing aE(1-325) showed
similar aggregation activity to the parental cell line R2/7.
These results demonstrated that the residues 325-509 includ-
ing the vinculin/a-actinin-binding domain are also involved
in cadherin-dependent cell aggregation activity in R2/7. In
the cell dissociation assay, R2/7 was readily dissociated but
R2/7 transfectants expressing aE(1-890) were hardly dis-
sociated (Fig. 9 C). Although cells expressing aE(1-325/
510-890) showed some degree of resistance to pipetting,
the strong state of cell adhesion activity was not fully re-
stored (Fig. 9 C). This partial restoration of the strong
state of cell adhesion activity was also observed in cells ex-
pressing not only aE(1-509) but also aE(1-325) (Fig. 9 C).
These results suggested that multiple domains of a-catenin
were required for the strong state of cell adhesion activity
in R2/7.
To confirm the importance of adhesion-modulation do-
main in epithelial cells, we used PC9 cells, a human lung
carcinoma cell line lacking a-catenin expression. It was re-
Figure 8. Detergent extraction of E-cadherin–a-catenin fusion
proteins. Soluble (S) and insoluble (I) fractions derived from 2 3
105 cells expressing nEaC(509-906), nEa(509-643), nEa(631-
906), and nEa(1-643) were separated by SDS-PAGE (10%) and
immunoblotted with anti–E-cadherin mAb. Several minor bands
with lower molecular mass, which may have been degradation
products of fusion molecules, were detected. Cell adhesion activ-
ity for each transfectants is represented by 1 or 2. Size markers
of 200, 116, and 97 kD are indicated on the left.The Journal of Cell Biology, Volume 144, 1999 1318
ported that PC9 showed aggregation activity to some ex-
tent and that this activity was dependent on E-cadherin–
b-catenin complex without a-catenin (Shimoyama et al.,
1992). We constructed an expression vector encoding
a(1-184/509-643), in which only an adhesion-modulation
domain was covalently connected to the NH2-terminal
b-catenin-binding domain of a-catenin (Fig. 10 A). This
vector was introduced into PC9 cells, and several transfec-
tant clones were isolated. a(1-184/509-643) with the ex-
pected size was expressed in the transfectants (Fig. 10 B)
and colocalized with E-cadherin–b-catenin complex (data
not shown). Cell aggregation assay revealed that cells ex-
pressing  a(1-184/509-643) aggregated more rapidly and
more extensively than parental PC9 cells (Fig. 10 C).
These aggregates were readily dissociated into single cells
under the dissociation assay conditions (data not shown).
These observations indicated that an adhesion-modulation
domain is involved in the weak state of cell adhesion activ-
ity even in epithelial cell lines.
Discussion
It is generally accepted that the cadherin–catenin cell ad-
hesion complex plays fundamental roles not only in the
formation of cell–cell junctions but also in the morphogen-
esis of tissue and organs, dependent on its strong state of
cell–cell adhesion activity and its interaction with the
actin-based cytoskeleton (Takeichi, 1991). We identified
three distinct functional domains of a-catenin required for
the interaction with vinculin, for direct binding to ZO-1,
and for the adhesion activity of E-cadherin–a-catenin fu-
sion molecules (Fig. 11 B). Here, we will discuss possible
functions of each domain of a-catenin and the relationship
between the cell adhesion activity and the interaction of
Figure 9. Aggregation and dissociation assay of R2/7 transfectants. (A) Schematic drawing of the mutant a-catenin constructs. The
amino acid residues of a-catenin contained in mutant molecules are shown in parentheses. T7 tag is connected at the COOH-terminal
end of each mutant. (B) Aggregation of R2/7 cells (open squares) and their transfectants expressing aE(1-890) (open circles), aE(1-325/
510-890) (closed circles), aE(1-509) (open triangles), and aE(1-325) (closed triangles). Cells dissociated by TC treatment in the pres-
ence of cytochalasin D were allowed to aggregate in the presence of 1 mM Ca21. The lower value on the ordinate represents the higher
degree of aggregation. (C) Dissociation of R2/7 (black bar) and its transfectants expressing aE(1-890) (hatched bar), aE(1-325/510-890)
(lightly hatched bar), aE(1-509) (dotted bar), and aE(1-325) (white bar). The lower value on the ordinate represents the lower degree
of dissociation.
Figure 10. Aggregation assay of PC9 transfectants. (A) Sche-
matic drawing of a(1-184/509-643). (B) Expression of a(1-184/
509-643) molecule. Total lysates derived from 2 3 105 PC9 cells
(lane 1) and PC9 cells expressing a(1-184/509-643) (lane 2) were
separated by SDS-PAGE and immunoblotted with anti–HA-tag
mAb, 12CA5. Size markers of 45 and 36 kD are indicated on the
right. (C) Aggregation of PC9 cells (open squares) and PC9 cells
expressing a(1-184/509-643) (closed circles). Cells dissociated by
TC treatment were allowed to aggregate in the presence of 1 mM
Ca21. The lower value on the ordinate represents the higher de-
gree of aggregation.Imamura et al. Functional Domains of a-Catenin 1319
cadherin–catenin complex with the cytoskeleton. We will
also discuss the difference of a-catenin function in nonepi-
thelial and in epithelial cells.
Functional Domains of a-Catenin
ZO-1-Binding Domain. a-Catenin was reported to be di-
rectly associated with b-catenin, a-actinin, and actin fila-
ments, and the domains responsible for their binding have
been narrowed down on the a-catenin molecule (Rimm
et al., 1995; Nieset et al., 1997; Obama and Ozawa, 1997).
It was reported recently that ZO-1 bound to a-catenin di-
rectly (Itoh et al., 1997), but the domain responsible re-
mained elusive. In this study, using deletion constructs, we
showed that the COOH-terminal domain (residues 631-
906) of a-catenin recruited ZO-1 to the cell adhesion sites
and directly bound to NH2-terminal half of ZO-1 in vitro.
We also demonstrated that this ZO-1-binding domain in-
teracted with cytoskeletons judging from the resistance of
fusion molecules to NP-40 extraction. It was reported pre-
viously that the COOH-terminal halves of ZO-1 are di-
rectly associated with actin filaments (Itoh et al., 1997).
Based on these properties, we can imagine that the ZO-
1-binding domain interact with the actin-based cytoskele-
ton through ZO-1. We demonstrated that this domain is
essential for the strong state of cadherin-based cell adhe-
sion in L cell transfectants, which was dependent on the in-
tact actin-based cytoskeleton. The functional importance
of the ZO-1-binding domain was also reported using mouse
embryos expressing mutant a-catenin (Torres et al., 1997).
Taken together, we concluded that the ZO-1-binding do-
main (COOH-terminal 276 residues) of a-catenin plays a
fundamental role in the cadherin–catenin cell adhesion
system probably through its interaction with ZO-1 and/or
the actin-based cytoskeleton.
We cannot exclude the possibility that other cytoskele-
tal proteins interact with the ZO-1-binding domain. This
domain is known to interact with actin in vitro (Rimm et al.,
1995). The physiological role of this interaction remains to
be elucidated. The ZO-1-binding domain was also shown
to directly interact with vinculin in vitro (Weiss et al.,
1998). However, we found that the ZO-1-binding domain
in fusion molecules did not recruit vinculin to the cell–cell
boundaries in L cell transfectants. Since the reported bind-
ing constant of the ZO-1-binding domain to vinculin was
lower than that to ZO-1 (Itoh et al., 1997; Weiss et al.,
1998), the binding of vinculin to the ZO-1-binding domain
may be prevented by ZO-1 in L cell transfectants. ZO-2
Figure 11. Functional domains of a-catenin in L cell transfectants. (A) Summary of each fusion molecule phenotype with regard to cy-
toskeleton interaction and cell adhesion activity. The table on the right indicates whether a given fusion protein was colocalized with
vinculin and a-actinin (vinculin/a-actinin) or ZO-1 (ZO-1) in transfectants (indicated as 1 or 2). Whether a given fusion protein func-
tioned as a cell adhesion molecule (adhesion activity) is also indicated (1 or 2). The states of adhesion activity are indicated as S
(strong state) or W (weak state). Heavily, lightly hatched, and cross-hatched boxes were required for vinculin/a-actinin-binding, ZO-
1-binding, and cell adhesion activity, respectively. (B) The functional domains identified in this study, i.e., the adhesion-modulation
domain (509-643 residues; cross-hatched), ZO-1-binding domain (631-906 residues; lightly hatched), and vinculin/a-actinin-binding do-
main (327-402 residues; heavily hatched), are indicated. These domains performed their functions independently. Both the adhesion-
modulation domain and ZO-1-binding domain were required for fusion molecules to show the strong state of cell adhesion activity.The Journal of Cell Biology, Volume 144, 1999 1320
and ZO-3, homologues of ZO-1, are other candidates as
binding proteins to the ZO-1-binding domain. In fact,
it was reported recently that ZO-2 showed very similar
properties with ZO-1 and directly bound to a-catenin
(Itoh et al., 1999). However, these proteins are not in-
volved in the cadherin-based cell adhesion in L cell trans-
fectants, since their expression was not detected in L cell
transfectants (our unpublished observation).
Domain Required for the Recruitment of Vinculin. We
found that residues 327-402 of a-catenin were required for
fusion molecules to recruit not only a-actinin but also vin-
culin in transfected L cells. This is consistent with previous
data that this domain directly binds to both vinculin
(Watabe-Uchida et al., 1998) and a-actinin (Nieset et al.,
1997), and these two molecules interact with each other
(Wachsstock et al., 1987). It is not clear whether vinculin
and a-actinin interact with this short domain with 76 resi-
dues simultaneously or competitively in vivo. E-cadherin–
a-catenin fusion molecules conferred full adhesion activity
in L cell transfectants even if they lacked the vinculin/
a-actinin-binding domain. This raised the question of what
is the function of the vinculin/a-actinin-binding domain.
We reported previously that intact E-cadherin conferred a
flexible adhesive phenotype upon L cells, but E-cadherin–
a-catenin fusion molecules conferred inflexible pheno-
types (Nagafuchi et al., 1994). If the vinculin/a-actinin-
binding domain is involved in this flexible adhesion activity,
its function would not be observed using E-cadherin–
a-catenin molecules expressed in L cells. On the other
hand, it was reported recently that this domain is involved
in the organization of apical junctional complex and the
activation of cadherin-based cell adhesion in epithelial
cells (Watabe-Uchida et al., 1998). It has been reported
also that vinculin is colocalized with the cadherin–catenin
complex in epithelial cells but not in some fibroblastic cell
lines (Knudsen et al., 1995), and that vinculin is one of the
major components of cell–cell AJ in epithelial cells (Gei-
ger et al., 1980). These observations suggest that the vincu-
lin/a-actinin-binding domain is required for the function of
cadherin–catenin complex, especially for junctional com-
plex formation, only in epithelial cells but not in fibroblas-
tic cells.
Functional Domain Involved in Cell Adhesion Activity.
Deletion constructs showed that residues 509-643 of a-cate-
nin are required for fusion molecules to function as cell
adhesion molecules. We tentatively called this domain
an adhesion-modulation domain. When mutant a-catenin
containing the b-catenin-binding and the adhesion-modu-
lation domains was expressed in a-catenin–deficient PC9
cells, such cells aggregated more rapidly than parental PC9
cells. These results suggested that the adhesion-modula-
tion domain is involved in cell adhesion in the “natural”
cadherin/catenin complex.
Although several sites of a-catenin were reported to be
required for the interaction with the cytoskeleton, the ad-
hesion-modulation domain does not correspond to these
cytoskeletal interaction sites. Moreover, the fusion mole-
cule carrying only this domain was easily extracted with
NP-40, suggesting that this molecule did not interact with
the cytoskeleton. These findings indicated that the adhe-
sion-modulation domain might function without the inter-
action with the cytoskeleton. It has been accepted that the
insoluble fraction of E-cadherin was active in cell adhesion
and the soluble one was not, since E-cadherin molecules
which could not be extracted with NP-40 were strictly lo-
calized at cell–cell contact sites (Nagafuchi and Takeichi,
1988). However, our present results suggested that some
fraction of soluble E-cadherin–catenin complex was also
active in cell adhesion.
The molecular mechanism of the activation of E-cad-
herin extracellular domain remains unclear. One simple
interpretation is that the adhesion-modulation domain
supports the lateral aggregation of E-cadherin molecules,
which may mediate the weak state of cell adhesion. Alter-
natively, this domain may trigger off the other adhesion-
modulation system. Fusion molecules used contained the
membrane proximal, p120-binding domain of E-cadherin
(Yap et al., 1998) and are colocalized with endogenous
p120 protein in transfected L cells (our unpublished obser-
vation). It was reported that this membrane proximal
domain might positively or negatively regulate cadherin-
based cell adhesion (Ozawa and Kemler, 1998; Yap et al.,
1998). It is possible that the adhesion-modulation domain
of a-catenin affects the potential activity of the membrane
proximal domain of E-cadherin.
Some fusion molecules lacking the adhesion-modulation
domain were detected at cell–cell boundaries in transfec-
tants, although nonfunctional E-cadherin itself was not
(Nagafuchi and Takeichi, 1988). These observations raised
the question of how these fusion molecules were con-
densed at cell–cell boundaries, although they did not
function as cell adhesion molecules. The main difference
between these fusion molecules and nonfunctional E-cad-
herin is that the former interacted with cytoskeletal pro-
teins such as ZO-1 or vinculin/a-actinin but the latter did
not. As discussed below, ZO-1 is likely to facilitate the lat-
eral aggregation of its membrane binding partners. Vincu-
lin is also expected to form clusters through its interaction
with various cytoskeletal components (Otto, 1990). So, the
interaction with cytoskeletal components may cause the
clustering of fusion molecules in the plasma membrane,
which then induces the association of cadherin complexes
on apposed cell membranes (Shapiro et al., 1995).
Relationship between Interaction with the Cytoskeleton 
and Adhesion Activity of Cadherin–Catenin Complex
As previously reported, cadherin-based cell adhesion can
be classified into the strong state and the weak state, using
cell dissociation and aggregation assays (Takeda et al.,
1995). In the cell aggregation assay, cells form aggregates
in both adhesive states. In the cell dissociation assay, how-
ever, cells in the strong state were hardly dissociated into
single cells but those in the weak state were dissociated
readily. It is known that the adhesive state is regulated by
the phosphorylation level of the cytoplasmic components
(Matsuyoshi et al., 1992; Behrens et al., 1993). We also
demonstrated that disorganization of the actin-based cy-
toskeleton shifted the cadherin-based cell adhesion from
the strong to the weak state. Since the level of cadherin ex-
pression on the cell surface was not affected in either case,
the strong state and the weak state may reflect qualitative
differences in cell adhesion activity but not quantitative
differences in cell adhesion molecules. The present resultsImamura et al. Functional Domains of a-Catenin 1321
are consistent with this idea, since cells in both adhesive
states aggregated in a similar manner.
We found that all of the fusion molecules that showed
the strong state of cell adhesion activity interacted with
the cytoskeleton, suggesting that the interaction with the
cytoskeleton is required for the strong state of cell adhe-
sion activity. This was supported by the present observa-
tion that cytochalasin D treatment shifted cadherin-based
cell adhesion to the weak state. Interestingly, the fusion
molecule lacking only the ZO-1-binding domain showed
the weak state of cell adhesion activity, although it con-
tained a vinculin/a-actinin-binding domain and may inter-
act with the cytoskeletons, judging from the refractoriness
to NP-40 extraction. Thus, we concluded that the cyto-
skeleton interaction through the ZO-1-binding domain,
but not through the vinculin/a-actinin binding domain or
other domain(s), is required for the strong state of cell ad-
hesion activity in L cell transfectants. As discussed above,
ZO-1 and actin are possible binding proteins to this do-
main in L cell transfectants. ZO-1 is a member of the
MAGUK family. Another member of this family, PSD95,
is known to facilitate the lateral aggregation of its mem-
brane binding partners such as NMDA receptors and K1
channels (Kim et al., 1995; Niethammer et al., 1996). Thus,
it is possible that ZO-1 strengthens the cell–cell adhesion
activity not only by cross-linking a-catenin to actin fila-
ments (Itoh et al., 1997) but also by facilitating the lateral
aggregation of E-cadherin or its fusion molecules in L cell
transfectants. The role of actin binding to this domain re-
mains unclear. Furthermore, we cannot exclude the pos-
sibility that unknown factor(s) interacted with the ZO-
1-binding domain and supported the strong state of cell
adhesion activity.
Function of a-Catenin in Epithelial Cells
At the immunoelectron microscopic level, cadherin–cate-
nin complex is known to be colocalized with ZO-1 in non-
epithelial cells such as L cells but not in epithelial cells. In
epithelial cells, ZO-1 is highly condensed at the TJ and is
thought to directly interact with TJ membrane proteins in-
cluding occludin (Furuse et al., 1994). These results sug-
gested that the ZO-1-binding domain of a-catenin may
have different functions in nonepithelial cells and in epi-
thelial cells. In fact, it was demonstrated that this domain
could not cause redistribution of ZO-1 in R2/7, an epithe-
lial colon carcinoma cell line (Watabe-Uchida et al., 1998).
It remains unclear why the ZO-1-binding domain does not
associate with ZO-1 and how this domain functions in epi-
thelial cells. Further studies to address this question will
provide important information regarding the mechanisms
of junctional complex formation in epithelial cells.
It was reported recently that the vinculin/a-actinin-bind-
ing domain directly binds to vinculin and this interaction
functions to organize the apical junctional complex, in-
cluding TJ, in R2/7 cells (Watabe-Uchida et al., 1998). This
domain, instead of the ZO-1-binding domain, functions to
recruit ZO-1 at cell–cell boundaries in R2/7 cells. Since we
demonstrated that this domain did not interact with ZO-1
directly, the redistribution of ZO-1 may be dependent on
the reorganization of TJ caused by a-catenin–vinculin in-
teraction in R2/7 cells. This is consistent with the previous
observation that, when the vinculin/a-actinin binding do-
main was replaced with the vinculin tail domain, the re-
sultant a-catenin–vinculin fusion molecule recruited ZO-1
to cell–cell boundaries (Watabe-Uchida et al., 1998).
The role of a-catenin in epithelial cell adhesion also
seems to be different from that in nonepithelial cells, al-
though the adhesion-modulation domain seems to be gen-
erally used in nonepithelial and epithelial cells. We found
that the ZO-1-binding domain, which cannot cause redis-
tribution of ZO-1, also failed to fully restore the strong
state of cell adhesion activity in epithelial cells, supporting
our speculation that ZO-1 is required for the strong state
of cell adhesion activity. In epithelial cells, both the NH2-
terminal half and COOH-terminal half domains are par-
tially involved in the strong state of cell adhesion activity
and these two domains cooperatively support this activity.
Thus, a-catenin in epithelial cells supports the strong state
of cell adhesion activity in a different manner from that in
nonepithelial cells. In fact, it was reported recently that
the COOH-terminal 236 residues, the in vitro binding do-
main to ZO-1, were not involved in the cadherin-based cell
adhesion activity in epithelial cells, although the COOH-
terminal 273 residues of a-catenin were involved in this ac-
tivity (Ozawa, 1998). The 37 residues between 634 and 670
of a-catenin were not involved in the adhesion activity or
binding to ZO-1 in L cell transfectants (our unpublished
observation). The mechanism by which a-catenin is in-
volved in these processes in epithelial cells remains to be
elucidated.
Of course, here, we cannot completely exclude the pos-
sibility that differences of a-catenin functions observed in
L cells and R2/7 cells are not due to differences of the cell
type (nonepithelium versus epithelium) but that of the ex-
pressed molecule (fusion versus nonfusion). However, our
recent observations using a-catenin–deficient F9 cells did
not favor this possibility (Maeno, Y., and A. Nagafuchi,
unpublished observations).
In this study, we identified three functional domains of
a-catenin, i.e., the ZO-1-binding domain, vinculin/a-acti-
nin-binding domain and adhesion-modulation domain. We
also clarified the effects of the cytoskeleton interaction on
the different states of cadherin-based cell adhesion activ-
ity. Furthermore, we demonstrated that a-catenin may
have different functions in nonepithelial and epithelial
cells. Further studies of the regulatory mechanism of cad-
herin-based cell adhesion by a-catenin will lead to a better
understanding of the physiological functions of the cad-
herin–catenin complex which plays a pivotal role in mor-
phogenesis in multicellular organisms.
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